2Miyashita T,Reed J.Bcl-2 oncoprotein blocks chemot herapy-induced apoptosis in a human leukemia cell line[].Blood.1993
3Lowe S W,Ruley H E,Jacks T et al.P53-dependent apoptosis modulates the cytotoxicity of anticancer agents[].Cell.1993
4Linn S C,Honkoop A H,Hoekman K et al.P53 and Pglycoprotein are often co-expressed are associated with poor prognosis in breast cancer[].British Journal of Cancer.1996
5Clifford S C,Neal D E,Lunee J.Alterations in express of the multidrug resistance-associated protein ( MRP )gene in high-grade transitional carcinoma of the bladder[].British Journal of Cancer.1996
6Oshika Y,Nakamura M,Tokunaga T et al.Multidrug resistance-associated protein and mutant P53 protein expression in non-small cell lung cancer[].Modern Pathology.1998
7Slapak C A,Fracasso P M,Martell R L et al.Overexpression of the multidrug resistance-associated protein( MRP) gene in vincristine but not doxorubicin-selected multidrug-resistance murine erythroleukemia cells[].Cancer Research.1994
8Rhodes T,Barrand M A,Twentyman P R et al.Modification by brefeldin A, bafilomycin A1, and 7-chloro-4nitrobenz-2-oxa-1, 3-diazole(NBD) of cellular accumulation and intracellular distribution of anthracyclines in the non-P-glycoprotein-mediated multidrug-resistant cell line COR-L23 R[].British Journal of Cancer.1994
9Eid H,Gulyas M,Geczi L et al.Expression of Bcl-2 in testicular carcinoma: correlation with tumor progression and MDR1 pgp[].Cancer.1998
10Wang Q,Beck W T.Transcripional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type P53[].Cancer Research.1998
1CLEGG H V, ITAHANA K, ZHANG Y. Unloc- king the Mdm2-p53 loop: ubiquitin is the key[J].ell Cycle, 2008,7:287-292.
2BOLDRINI L, GISFRED1 S, URS1NO S. Eftect of the p53 eodon 72 and intron 3 polymorphisms on non- small cell lung cancer (NSCLC) prognosis[J].Canc- er Invest, 2008,26:168 -172.
3FAGHANI M, GHASEMI F M, NIKHBAKHT M, et al. TP53 P1N3 polymorphism associated with breast cancer risk in Iranian women [J].Indian J Cancer,2011, 48:298-302.
4MALIK M A, SHARMA K, GOEI. S, et al. Asso ciation of TP53 intron 3, 16 bp duplication polymor phism with esophageal and gastric cancer susceptibili ty in Kashmir Valley[J]. Oncol Res, 2011,19(3 - 4) :165-169.
5HU Z, L1 X, QU X, et al. Intron 3 16 bp duplication polymorphism of TP53 contributes to cancer suscep- tibility~ a recta-analysis[J]. Carcinogenesis, 2010, 31:643-647.
